Penobscot Investment Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-20,370
Closed -$869K 186
2015
Q4
$869K Sell
20,370
-3,430
-14% -$158K 0.27% 92
2015
Q3
$1.13M Sell
23,800
-1,080
-4% -$55K 0.38% 75
2015
Q2
$1.23M Sell
24,880
-1,050
-4% -$53.2K 0.38% 77
2015
Q1
$1.28M Sell
25,930
-180
-0.7% -$8.61K 0.41% 74
2014
Q4
$1.19M Sell
26,110
-22,430
-46% -$1.09M 0.37% 79
2014
Q3
$2.74M Buy
48,540
+760
+2% +$40.8K 0.91% 38
2014
Q2
$2.54M Buy
47,780
+610
+1% +$32.4K 0.85% 43
2014
Q1
$2.47M Buy
47,170
+280
+0.6% +$14.2K 0.87% 40
2013
Q4
$2.51M Buy
46,890
+330
+0.7% +$17K 0.89% 38
2013
Q3
$2.36M Buy
46,560
+2,070
+5% +$105K 0.92% 37
2013
Q2
$2.29M Buy
+44,490
New +$2.37M 0.96% 35

Other funds holding SNY

Penobscot Investment Management's SNY Position: Q1 2016 in Review

Penobscot Investment Management sold out of Sanofi (SNY) in Q1 2016, closing a stake of 20,370 shares — an estimated $869K sold.

Penobscot Investment Management first reported a position in SNY in Q2 2013 and held it in 11 quarters. The position peaked at $2.74M in Q3 2014. 449 funds tracked by Wall St. Rank hold SNY as of Q1 2016.

  • Penobscot Investment Management reported no remaining Sanofi position as of Q1 2016 after selling out during the quarter.
  • Penobscot Investment Management sold 20,370 Sanofi shares in Q1 2016, an estimated $869K.
  • Penobscot Investment Management first reported a position in Sanofi in Q2 2013 and held it in 11 quarters.
  • Penobscot Investment Management's Sanofi position peaked at $2.74M in Q3 2014.
  • 449 funds tracked by Wall St. Rank held Sanofi as of Q1 2016.

Based on Penobscot Investment Management's 13F filing for Q1 2016, filed 16 May 2016.